This website uses cookies to enhance the user experience.
21st logo
||
A

ADVANCE INVEST & CONSULTING AS985 393 338

Limited company
Grefsenkollveien 2 0490 OSLO, Norge

ADVANCE INVEST & CONSULTING AS

Operating
Rådgivningstjenester innen bioteknologi og farmasi, herunder å delta i nadre selskaper med lignende virksomhet, og kjøp og salg av aksjer innen bioteknologi og farmasi.
Rådgivning og investeringsvirksomhet.

Organization

Chairman of the board
Years since formation
23 years
since Feb 15, 2003
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
1,615
1 share class
Total number of shareholders
1
person

Financials

Annual total result 2025
552,009
NOK
Total equity 2025
6,786,445
NOK
Last update: Jul 8, 2026

Management

Board

NameRoleShares
Chairman-
Board Member-
Alternate Member-

Others

NameRoleShares
A
AZETS INSIGHT AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
100 %
directly
Last update: Sep 24, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
1,615
100 %

Shares owned by the ADVANCE INVEST & CONSULTING AS

NameShare classTotal number of sharesShare
N
NAVAMEDIC ASA
Ordinary shares
40,000
0.17 %
S
SPOTLIO AS
Ordinary shares
46,000
0.02 %
O
ONCOINVENT ASA
Ordinary shares
70,000
0.02 %
N
NORSKE SKOG ASA
Ordinary shares
3,000
< 0.01 %
O
OTOVO ASA
Ordinary shares
70,000
< 0.01 %
N
Norsk Hydro ASA
Ordinary shares
6,000
< 0.01 %
B
BERGEN CARBON SOLUTIONS AS
Ordinary shares
6,000
< 0.01 %
E
EQUINOR ASA
Ordinary shares
750
< 0.01 %
K
KONGSBERG GRUPPEN ASA
Ordinary shares
1,000
< 0.01 %
S
SCATEC ASA
Ordinary shares
2,250
< 0.01 %
T
THOR MEDICAL ASA
Ordinary shares
20,000
< 0.01 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
552,009
1,202,899
279,410
181,129
180,363
Total assets
6,787,033
6,242,356
5,038,485
4,756,314
4,572,872
Total liabilities
588
7,920
6,949
4,188
1,875
Total equity
6,786,445
6,234,436
5,031,536
4,752,126
4,570,997

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
26,219
27,806
36,377
33,310
24,055
Operating result
-26,219
-27,806
-36,377
-33,310
-24,055
Financial income/costs
578,817
1,259,956
326,178
209,942
199,839
Profit before tax
552,597
1,232,150
289,801
176,632
175,784
Total tax & extraordinary income/cost
588
29,251
10,391
-4,497
-4,579
Annual Total Result
552,009
1,202,899
279,410
181,129
180,363

Balance overview

Year20252024202320222021
Total fixed assets
0
0
21,330
31,721
27,224
Total current assets
6,787,033
6,242,356
5,017,155
4,724,593
4,545,648
Total assets
6,787,033
6,242,356
5,038,485
4,756,314
4,572,872
Short term debt
588
7,920
6,949
4,188
1,875
Long term debt
0
0
0
0
0
Total liabilities
588
7,920
6,949
4,188
1,875
Contributed capital
209,950
209,950
209,950
209,950
209,950
Retained earnings
6,576,495
6,024,486
4,821,586
4,542,176
4,361,047
Total equity
6,786,445
6,234,436
5,031,536
4,752,126
4,570,997
Total equity and liabilities
6,787,033
6,242,356
5,038,485
4,756,314
4,572,872

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Standard industrial classification